title: Effects of gabapentin on pain and opioid consumption after abdominal hysterectomy.
abstract: BACKGROUND
  Postoperative pain is an important factor affecting anesthesia and surgery.
  
  
  OBJECTIVE
  The present study assessed the effects of 1200 mg gabapentin, an anticonvulsant drug that acts through voltage-dependent calcium channels, for the control of postoperative pain in patients undergoing abdominal hysterectomy.
  
  
  METHODS
  Fifty patients undergoing hysterectomy were enrolled in the present study. Subjects received either 1200 mg gabapentin or placebo 2 h before surgery. The amount of morphine consumption and level of postoperative pain at 2 h, 6 h, 12 h and 24 h after surgery were measured.
  
  
  RESULTS
  There were no significant differences in age, duration of surgery and anesthesia, or body mass index between the two groups. The mean intensity of pain in the gabapentin group was significantly lower than in the placebo group. The mean amount of morphine used in the placebo group (5.2 ± 2.8 mg) was significantly higher than in gabapentin group (1.2 ± 0.29 mg; P=0.001). Nausea and vomiting in the placebo group was more common than in the gabapentin group (P=0.001). The time interval for initial ambulation after surgery was significantly shorter in the gabapentin group (12.24 ± 2.18 h) compared with the placebo group (15 ± 3.61 h; P=0.002).
  
  
  CONCLUSIONS
  1200 mg gabapentin reduced postoperative pain and the need for opioids, and enabled earlier ambulation of the patient. Significant side effects were not observed.
authors: Department of Obstetrics and Gynecology, Kashan University of Medical Services, Iran.
authors: Fatemeh
authors: F
authors: Frouzanfard
authors: Mohammad Reza
authors: MR
authors: Fazel
authors: Azadeh
authors: A
authors: Abolhasani
authors: Esmaeil
authors: E
authors: Fakharian
authors: Golmabas
authors: G
authors: Mousavi
authors: Alireza
authors: A
authors: Moravveji
mesh_terms: D000328:Adult; D000588:Amines / Q000627:therapeutic use*; D000700:Analgesics / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D016009:Chi-Square Distribution; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D000077206:Gabapentin; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects*; D008875:Middle Aged; D010147:Pain Measurement; D010149:Postoperative Pain / Q000209:etiology* / Q000517:prevention & control*; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
chemical_list: D000588:Amines; D000700:Analgesics; D000701:Analgesics, Opioid; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin
references: Anesthesiology. 2004 Apr;100(4):935-8
references: 15087630
references: Epilepsy Res. 1993 Dec;16(3):175-81
references: 8119268
references: Am J Psychiatry. 1998 Jul;155(7):992-3
references: 9659873
references: Can J Anaesth. 2006 Mar;53(3):268-73
references: 16527792
references: Anesthesiology. 2002 Sep;97(3):560-4
references: 12218520
references: J Biol Chem. 1996 Mar 8;271(10):5768-76
references: 8621444
references: J Neurol. 2004 Oct;251(10):1260-6
references: 15503108
references: JAMA. 1998 Dec 2;280(21):1831-6
references: 9846777
references: Acta Anaesthesiol Scand. 2004 Mar;48(3):322-7
references: 14982565
references: Anesthesiology. 2002 Sep;97(3):537-9
references: 12218517
references: Saudi J Anaesth. 2010 Sep;4(3):137-41
references: 21189848
references: Clin J Pain. 2010 Jun;26(5):381-5
references: 20473044
references: Anesth Analg. 2004 May;98(5):1370-3, table of contents
references: 15105217
references: JAMA. 1998 Dec 2;280(21):1837-42
references: 9846778
references: J Neurosurg Anesthesiol. 2005 Jul;17(3):125-8
references: 16037731
references: Acta Anaesthesiol Scand. 2004 May;48(5):525-46
references: 15101847
references: J Neurosurg Anesthesiol. 2005 Apr;17(2):65-8
references: 15840990
references: BMC Anesthesiol. 2006 Nov 03;6:12
references: 17083725
references: Br J Pharmacol. 2000 Sep;131(2):282-6
references: 10991921
references: Anesthesiology. 2003 May;98(5):1288-92
references: 12717156
references: Can J Psychiatry. 1998 Apr;43(3):305
references: 9561320
references: Anesth Analg. 2000 Jul;91(1):185-91
references: 10866910
references: Acta Anaesthesiol Scand. 2007 Mar;51(3):299-304
references: 17257177
references: Br J Pharmacol. 2002 Jan;135(1):257-65
references: 11786502
references: Anesth Analg. 2006 Nov;103(5):1278-82
references: 17056969
references: Pain. 2004 Jul;110(1-2):175-81
references: 15275765